Cover image not available

Costing statement : Cetuximab for the treatment of recurrent and/or metastatic squamous cell cancer of the head and neck

National Institute for Health and Clinical Excellence

Publication Data

Title Costing statement : Cetuximab for the treatment of recurrent and/or metastatic squamous cell cancer of the head and neck
Alternative Title Cetuximab for the treatment of recurrent and/or metastatic squamous cell cancer of the head and neck
Author National Institute for Health and Clinical Excellence
Publisher National Institute for Health and Clinical Excellence
Publication date 0000
Publication location London

Topics

Squamous cell carcinoma :: Chemotherapy :: Great Britain :: Cost effectiveness
Head :: Cancer :: Chemotherapy :: Great Britain :: Cost effectiveness
Neck :: Cancer :: Chemotherapy :: Great Britain :: Cost effectiveness
England

Catalogue Data

OBNB ID GBB586042
ISBN 10 n/a
ISBN 13 n/a
Type BibliographicResource, Book
Dewey Classification 616.994061

ISBD

P1053 1 online resource (2 pages)
P1042 Includes bibliographical references.

Buy a copy

OBNB doesn't sell books, but you may be able to find a copy at one of these websites:

Costing statement : Cetuximab for the treatment of recurrent and/or metastatic squamous cell cancer of the head and neck by National Institute for Health and Clinical Excellence. Published by National Institute for Health and Clinical Excellence. Publication and catalogue information, links to buy online and reader comments.